Japan focus: 2025 nutraceutical regulations, top 2024 articles, Kirin’s health science ambitions, and Meiji’s yogurt research

Japan focus
Japan focus (Getty Images)

This edition covers new nutraceutical regulations and trends shaping APAC in 2025, NutraIngredients-Asia’s top 10 most-read articles of 2024, Kirin’s 300bn yen revenue target for its health science business, and Meiji’s decade-long yogurt research partnership with a Bulgarian firm.

New nutra regulations that come into force in 2025: What you should know

We piece together the new nutraceutical regulations that will be implemented this year, don’t miss the new policies to be introduced in major APAC nutraceutical markets, including Australia, China, India, Japan, and South Korea.

Nutra trends 2025: Five key consumer health trends set to drive APAC forward

We look at five key consumer health trends that companies active in Asia-Pacific are focusing on for this year, and their reasons for doing so.

NutraIngredients-Asia’s top 10 most-read news articles in 2024 revealed

We reveal the top 10 most-read news articles on NutraIngredients-Asia for year 2024, where stories on nutraceuticals’ quality and safety have grabbed the most attention.

Kirin sets 300bn yen revenue goal for health science business

Kirin has outlined a series of initiatives that will combine its strengths, as well as that of subsidiaries FANCL and Blackmores, in achieving a revenue of 300bn yen (US$1.95bn) for its health science business by 2030.

Yogurt and longevity? Meiji signs 10-year research contract with Bulgarian firm

Japanese dairy and confectionary firm Meiji has signed a 10-year joint research agreement with a Bulgarian firm, with the aim of uncovering the links between the gut, yogurt, and longevity.